4H-1-Benzopyran-4-one, 2-(3,5-dihydroxyphenyl)-5,7-dihydroxy-

Details

Top
Internal ID bc3e9829-6281-4f96-85e1-f3f4c6c6269d
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavones
IUPAC Name 2-(3,5-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
SMILES (Canonical) C1=C(C=C(C=C1O)O)C2=CC(=O)C3=C(C=C(C=C3O2)O)O
SMILES (Isomeric) C1=C(C=C(C=C1O)O)C2=CC(=O)C3=C(C=C(C=C3O2)O)O
InChI InChI=1S/C15H10O6/c16-8-1-7(2-9(17)3-8)13-6-12(20)15-11(19)4-10(18)5-14(15)21-13/h1-6,16-19H
InChI Key LRDGATPGVJTWLJ-UHFFFAOYSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H10O6
Molecular Weight 286.24 g/mol
Exact Mass 286.04773803 g/mol
Topological Polar Surface Area (TPSA) 107.00 Ų
XlogP 1.40
Atomic LogP (AlogP) 2.28
H-Bond Acceptor 6
H-Bond Donor 4
Rotatable Bonds 1

Synonyms

Top
74805-73-5
2-(3,5-Dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
4H-1-Benzopyran-4-one, 2-(3,5-dihydroxyphenyl)-5,7-dihydroxy-
DTXSID80225779

2D Structure

Top
2D Structure of 4H-1-Benzopyran-4-one, 2-(3,5-dihydroxyphenyl)-5,7-dihydroxy-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9671 96.71%
Caco-2 + 0.8222 82.22%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Mitochondria 0.6655 66.55%
OATP2B1 inhibitior - 0.5465 54.65%
OATP1B1 inhibitior + 0.9598 95.98%
OATP1B3 inhibitior + 0.9480 94.80%
MATE1 inhibitior + 0.6600 66.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.8183 81.83%
P-glycoprotein inhibitior - 0.8379 83.79%
P-glycoprotein substrate - 0.9363 93.63%
CYP3A4 substrate - 0.5759 57.59%
CYP2C9 substrate - 0.6443 64.43%
CYP2D6 substrate - 0.8503 85.03%
CYP3A4 inhibition + 0.9580 95.80%
CYP2C9 inhibition + 0.7746 77.46%
CYP2C19 inhibition + 0.7043 70.43%
CYP2D6 inhibition - 0.9231 92.31%
CYP1A2 inhibition + 0.9222 92.22%
CYP2C8 inhibition + 0.4711 47.11%
CYP inhibitory promiscuity + 0.7316 73.16%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.6044 60.44%
Eye corrosion - 0.9858 98.58%
Eye irritation + 0.9741 97.41%
Skin irritation + 0.5532 55.32%
Skin corrosion - 0.9784 97.84%
Ames mutagenesis - 0.5800 58.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7483 74.83%
Micronuclear + 0.8200 82.00%
Hepatotoxicity - 0.5875 58.75%
skin sensitisation - 0.9060 90.60%
Respiratory toxicity + 0.5333 53.33%
Reproductive toxicity + 0.6556 65.56%
Mitochondrial toxicity - 0.5250 52.50%
Nephrotoxicity - 0.5865 58.65%
Acute Oral Toxicity (c) III 0.7012 70.12%
Estrogen receptor binding + 0.8297 82.97%
Androgen receptor binding + 0.7854 78.54%
Thyroid receptor binding + 0.7008 70.08%
Glucocorticoid receptor binding + 0.7757 77.57%
Aromatase binding + 0.8013 80.13%
PPAR gamma + 0.8763 87.63%
Honey bee toxicity - 0.8440 84.40%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.6300 63.00%
Fish aquatic toxicity + 0.8272 82.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.23% 91.11%
CHEMBL3194 P02766 Transthyretin 94.81% 90.71%
CHEMBL1806 P11388 DNA topoisomerase II alpha 93.45% 89.00%
CHEMBL1951 P21397 Monoamine oxidase A 90.39% 91.49%
CHEMBL2581 P07339 Cathepsin D 88.88% 98.95%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 87.66% 94.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.33% 95.56%
CHEMBL1929 P47989 Xanthine dehydrogenase 86.97% 96.12%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 85.18% 99.15%
CHEMBL3401 O75469 Pregnane X receptor 83.96% 94.73%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 83.87% 90.71%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.36% 99.23%
CHEMBL1978 P11511 Cytochrome P450 19A1 80.47% 91.76%

Cross-Links

Top
PubChem 5487757
NPASS NPC94786
LOTUS LTS0134443
wikiData Q83104922